Breadcrumb
NIH Guide: Weekly Index for November 3, 2023
Weekly NIH Funding Opportunities and Notices
November 3, 2023
Policy Notices
-
NIH Will Send Reminder Notifications to Recipients with Final Federal Financial Reports (FFRs) in Rejected Status Beginning November 2023
(NOT-OD-24-017)National Institutes of Health
General Notices
-
Notice of NCI's Participation in RFA-HG-23-002, Broadening Opportunities for Computational Genomics and Data Science Education (UE5 Clinical Trial Not Allowed)
(NOT-CA-24-006)National Cancer Institute
-
Notice of NIDCR participation in PAR-23-303, Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)"
(NOT-DE-24-006)National Institute of Dental and Craniofacial Research
-
Notice of Participation of the All of Us Research Program in NOT-ES-23-016: Request for Information (RFI): Environmental Justice Research Gaps, Opportunities and Capacity Building
(NOT-PM-24-001)Office of the Director, NIH
-
Notice of Information: Technical Assistance Webinar for PAR-22-167: Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
(NOT-TR-24-003)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
-
Notice of Participation of the Food and Drug Administration in PAR-22-167, Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
(NOT-TR-24-005)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
-
Request for Information (RFI): Inviting Comments and Suggestions on the National Cancer Institutes Support of Early Career, Mentored Cancer Researchers and Trainees
(NOT-CA-24-007)National Cancer Institute
Notice of Changes to Funding Opportunities
-
Notice of Change to Eligibility Information for RFA-AG-24-040, "Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)"
(NOT-AG-23-069)National Institute on Aging
-
Notice of Early Expiration of Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives", NOT-AI-23-049
(NOT-AI-23-063)National Institute of Allergy and Infectious Diseases
-
Notice of NIDA's participation in PAR-23-309, "Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)"
(NOT-DA-23-043)National Institute on Drug Abuse
-
Notice of Change to Application Instructions for Application and Admissions Data in PAR-21-189 "Medical Scientist Training Program (T32)"
(NOT-GM-24-004)National Institute of General Medical Sciences
-
Notice of Change to Application Instructions for Application and Admissions Data Attachment in PAR-23-030 "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) (T32)"
(NOT-GM-24-005)National Institute of General Medical Sciences
-
Notice of Correction to PAR-23-309, Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
(NOT-MD-23-021)National Institute on Minority Health and Health Disparities
-
Notice to Extend Response Date for NOT-NR-23-018: "NINR Request for Information (RFI): Advancing Nursing Research in Climate and Health"
(NOT-NR-24-001)National Institute of Nursing Research
-
Notice of Change to Award Budget for SBIR/STTR Commercialization Readiness Pilot Program (CRP)
(NOT-OD-24-018)Office of the Director, NIH
-
Notice of Clarification and Correction Regarding Certification Letters for PA-23-271 "Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)"
(NOT-OD-24-024)Office of the Director, NIH
-
Notice of FY2024 Cohort Kick-off Locations for PAR-22-073, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
(NOT-OD-24-025)Office of the Director, NIH
-
Notice of Change to Update Part 2, Section III, PAR-22-167, Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
(NOT-TR-24-004)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notices of Intent to Publish
-
Notice of Intent to Publish: Alcohol-associated Hepatitis Clinical Network Late Phase Clinical Trials
(NOT-AA-24-001)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
(NOT-AI-23-075)National Institute of Allergy and Infectious Diseases
-
Notice of Intent to Publish a Funding Opportunity Announcement to Create State-based Healthcare Extension Cooperatives to Accelerate Implementation of Actionable Evidence into Practice
(NOT-HS-24-003)Agency for Healthcare Research and Quality
-
Notice of Intent to Publish a Funding Opportunity Announcement for Translational Neural Devices (R61/R33 - Clinical Trial Optional)
(NOT-NS-24-021)National Institute of Neurological Disorders and Stroke
Notices of Special Interest
-
Notice of Special Interest (NOSI): Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-23-189 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(NOT-AA-23-020)National Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences Research
-
Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives
(NOT-AI-23-076)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease
(NOT-DE-23-007)National Institute of Dental and Craniofacial Research
-
Notice of Special Interest: Administrative Supplements to Support Emerging Physician-Scientists to Develop Research Expertise in Diabetes, Endocrinology and Metabolic Diseases
(NOT-DK-23-021)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation (HCT)
(NOT-HL-23-116)National Heart, Lung, and Blood Institute
-
Notice of Special Interest (NOSI): Collaborative and Innovative Research to Advance Regulatory Science: Partnership of FDA Centers of Excellence in Regulatory Science and Innovation (CERSI) and NIH Clinical and Translational Science Award (CTSA) Programs
(NOT-TR-24-006)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Funding Opportunities
-
NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
(PAR-23-282)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
(PAR-23-293)National Human Genome Research InstituteNational Institute of Allergy and Infectious DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeOffice of Research on Women's HealthOffice of Behavioral and Social Sciences ResearchNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): Multiple dates, see announcement.
-
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
(PAR-23-294)National Human Genome Research InstituteNational Institute of Allergy and Infectious DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeJohn E. Fogarty International CenterOffice of Research on Women's HealthOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): January 12, 2025
-
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
(PAR-23-295)National Human Genome Research InstituteNational Institute of Allergy and Infectious DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthJohn E. Fogarty International CenterOffice of Research on Women's HealthOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): January 12, 2025
-
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
(PAR-23-313)National Cancer InstituteApplication Receipt Date(s): October 14, 2024
-
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
(PAR-23-314)National Cancer InstituteApplication Receipt Date(s): October 15, 2024
-
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
(PAR-24-039)National Cancer InstituteApplication Receipt Date(s): November 17, 2026
-
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
(PAR-24-043)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): September 24, 2024
-
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
(PAR-24-049)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
(PAR-24-063)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): August 18, 2026
-
Single Source: AIDS and Cancer Specimen Resource (ACSR; UM1 Clinical Trials Not Allowed)
(RFA-CA-23-043)National Cancer InstituteApplication Receipt Date(s): January 9, 2024
-
Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional)
(RFA-DA-25-021)National Institute on Drug AbuseApplication Receipt Date(s): Not Applicable
-
Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional)
(RFA-DA-25-022)National Institute on Drug AbuseApplication Receipt Date(s): November 15, 2024
-
Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional)
(RFA-DA-25-058)National Institute on Drug AbuseApplication Receipt Date(s): February 28, 2024
-
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)
(RFA-HD-25-008)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): March 29, 2024
-
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)
(RFA-MH-24-180)National Institute of Mental HealthApplication Receipt Date(s): March 1, 2024
-
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
(RFA-MH-24-181)National Institute of Mental HealthApplication Receipt Date(s): March 1, 2024
-
Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed)
(RFA-NR-24-002)National Institute of Nursing ResearchApplication Receipt Date(s): July 1, 2024
-
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
(RFA-NS-24-019)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Center for Complementary and Integrative HealthApplication Receipt Date(s): January 7, 2027
-
BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
(RFA-NS-24-028)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): August 19, 2024
-
IND-enabling Studies for Platform Clinical Trials of Genome Editing in Multiple Diseases (U01 Clinical Trial Not Allowed)
(RFA-RM-24-001)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): February 22, 2024
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: February 18, 2025
For technical issues E-mail OER Webmaster